Symptoms and General Pathology

All Conditions

Neoplasms

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Gland and Hormone Related Diseases

Syndrome

Polycystic Ovary Syndrome

Cysts

Ovarian Cysts

Ovarian Diseases

Adnexal Diseases

Genital Diseases, Female

Genital Diseases

Urogenital Diseases

Female Urogenital Diseases

Pregnancy Complications

Female Urogenital Diseases and Pregnancy Complications

Gonadal Disorders

Endocrine System Diseases

All Drugs and Chemicals

Anticoagulants

Reproductive Control Agents

Other Dietary Supplements

Hormones

Citric Acid

Sodium Citrate

Clomiphene

Enclomiphene

Zuclomiphene

Estrogens

Estrogen Antagonists

Estrogen Receptor Antagonists

Hormone Antagonists

Estrogen Receptor Modulators

Selective Estrogen Receptor Modulators

Citrate

AMH level is measured before Clomiphene citrate 100 mg daily for 5 days \& detecting Follicular growth assessment by TVU will be performed at day 12 of the menstrual period. Successful and unsuccessful follicular growth will be compared according to the subjects' respective AMH levels.

100 mg daily will be provided to the subjects to be taken for 5 days starting from day 2 of their spontaneous periods

Clomiphene Citrate

Follicular growth assessment by TVU will be performed at day 12 of the menstrual period.

Follicular growth

Polycystic ovary syndrome (PCOS) is found in 5% to 6% of women of reproductive age. It affects women's reproductive capability; thus patients have risks of infertility, miscarriage, and complicated pregnancy. A study revealed that the prevalence of oligoovulation or anovulation in patients with PCOS ranged from 65% to 80%. Anti-Mullerian Hormone (AMH) is an important regulator in the ovary that play a rule during development and function. It is suspected to affect clomiphene citrate (cc) resistance. In this study the investigator will assess the accuracy of AMH prediction of response to cc in women with PCOS.

Anti-Mullerian Hormone as Predictor of Ovarian Responce to Clomiphene Citrate in PCOS

Circulating Anti-mullerian Hormone as Predictor of Ovarian Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome

AMH level is measured 10 days before expected date of ovulation then correlated to ovulation either successfully or not.

Ain Shams University

Resident of obs & gyn.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Anti-Mullerian Hormone as Predictor of Ovarian Responce to Clomiphene Citrate in PCOS	NCT03316469	Polycystic Ovar...	Clomiphene Citr... Follicular grow...	20 Years - 35 Years	Ain Shams University
Anti-Mullerian Hormone as Predictor of Ovarian Responce to Clomiphene Citrate in PCOS	NCT03316469	Polycystic Ovar...	Clomiphene Citr... Follicular grow...	20 Years - 35 Years	Ain Shams University

Spots Global Cancer Trial Database for follicular growth